Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × canakinumab × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 4 Triple Negative Breast Neoplasms 1 Rheumatoid Arthritis, Systemic Juvenile 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Periodic Fevers Syndrome 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Mevalonate Kinase Deficiency 1 Metastatic Pancreatic Ductal Adenocarcinoma 1 Melanoma 1 Leukemia, Myelomonocytic, Chronic 1 Intestinal Neoplasms 1 Gastrointestinal Neoplasms 1 Cryopyrin-Associated Periodic Syndromes 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Clonal Cytopenia of Undetermined Significance 1 Carcinoma, Renal Cell 1 Carcinoma, Ductal 1 Carcinoma 1 Bronchiolitis Obliterans Syndrome 1 Breast Neoplasms 1 Arthritis, Juvenile 1 Arthralgia 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Nivolumab 130 Sunitinib 120 pembrolizumab 116 Sorafenib 75 Everolimus 67 cabozantinib 66 Bevacizumab 66 pazopanib 60 Ipilimumab 55 Axitinib 55 aldesleukin 48 Magnetic Resonance Spectroscopy 41 Cyclophosphamide 36 Interleukin-2 33 Radiosurgery 32 Interferon-alpha 32 lenvatinib 31 Specimen Handling 29 temsirolimus 27 atezolizumab 24 belzutifan 21 fludarabine phosphate 20 Gemcitabine 20 avelumab 18 Radiotherapy 18 Interferon alpha-2 17 Biopsy 16 fludarabine 15 durvalumab 15 Paclitaxel 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04028245 2025-08-07

SPARC-1

Columbia University

Phase EARLY_PHASE1 Active not recruiting

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡